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1078–5884/00The Influence of Subintimal Angioplasty on Level of
Amputation and Limb Salvage Rates in Lower Limb Critical
Ischaemia: A 15-year Experience
N. Hynes, B. Mahendran, B. Manning, E. Andrews, D. Courtney and S. Sultan*Department of Vascular and Endovascular Surgery, Western Vascular Institute, University College Hospital,
Galway, IrelandObjectives. The aim of this study is to assess the influence of subintimal angioplasty (SIA) on lower limb amputation rate
and level in critically ischaemic limbs.
Methods. Between January 1989 and March 2004, 1268 patients were admitted for treatment of lower limb critical
ischaemia. Eight hundred and twenty-nine patients underwent revascularisation (bypass 671 and angioplasty 158), while
439 patients had primary amputations. A retrospective analysis of a prospectively maintained vascular registry was
performed.
Patients were divided into two groups, those who were admitted prior to the availability of subintimal angioplasty and those
treated post-introduction of angioplasty. The two groups were compared with regards to age, sex, diabetes mellitus, ASA
grade, Rutherford classification and level of disease. Outcome was assessed by the limb salvage rate, 30-day morbidity and
mortality, and length of hospital stay.
Results. The average number of revascularisation increased with the introduction of subintimal angioplasty, from 53 to 96
per year (p!0.001). The overall limb salvage rate increased significantly from 42 to 70% (p!0.001). The cumulative limb
salvage rate following revascularisation rose from 72 to 86% (p!0.001). The level of amputation (AKA:BKA) did not vary
significantly. Thirty-day morbidity, mortality and length of hospital stay were significantly lower in the post-angioplasty
group.
Conclusions. Technical advances have resulted in a steadying of amputation numbers despite an ageing population.Keywords: Subintimal angioplasty; Critical limb ischaemia; Amputation; Limb salvage rate; Amputation level.Introduction
Critical lower limb ischaemia is a major component of
the workload of vascular units, and accounted for 86%
of total amputations in our institution over the last 15
years, with 35% of patients with CLI being treated
with primary amputation. The European consensus
document on chronic critical leg ischaemia1 estimated
the incidence of CLI at 50–100 per 100,000 population
per year, and this incidence is rising as the age of our
population increases.
Options include conservative management, angio-
plasty, arterial bypass surgery, and amputation. The
choice of management is dependant on a number of
factors including clinical presentation (Rutherfording author. Mr Sherif Sultan, Consultant Vascular and
Surgeon, Department of Vascular and Endovascular
tern Vascular Institute, University College Hospital,
nd.
: sherifsultan@esatclear.ie
0291 + 09 $35.00/0 q 2005 Elsevier Ltd. All rights reserclassification),2 TASC classification of lesion,3 and
patient fitness for surgery (ASA grade). The Joint
Vascular Research Group of the UK found that 60% of
patients were suitable for revascularisation, while a
further 20% needed an amputation.4 It is nearly 20
years since, this paper was published and these figures
have changed considerably. Evidence has shown that
appropriately performed revascularisation leads to
high patency rates and significantly reduced amputa-
tion rates in specialised vascular and endovascular
units.5,6 The greater cost effectiveness of revascularisa-
tion compared to amputation and the fact that it offers
a possibility for the patient to maintain independence
in daily activities, further stimulates the increase in
revascularisation.7
We have previously reported a prospective parallel
group comparison that suggests subintimal angio-
plasty improves limb salvage.8 In this study we aimed
to examine our service as a whole, mindful of the fact
that the West of Ireland has a higher old (O65 years)Eur J Vasc Endovasc Surg 30, 291–299 (2005)
doi:10.1016/j.ejvs.2005.04.020, available online at http://www.sciencedirect.com onved.
N. Hynes et al.292dependency ratio, at 22.6, than any other region in the
country.1 The aim of this study is to investigate the
trends in CLI management in our centre over the last
15 years and to determine if the recent establishment
of a specialized vascular and endovascular unit
adequately services our aging population and has
led to any change in referral pattern, patient numbers
and disease presentation. Furthermore, we wished to
investigate if the introduction of specialized tech-
niques, in this case subintimal angioplasty, have led to
any changes in limb salvage, amputation rate and level
of amputation.Materials and Methods
This is a population based epidemiological analysis,
performed in the Western region of Ireland, to which
University College Hospital Galway is a tertiary
referral centre. Its catchment area is in excess of
750,000. UCHG had one consultant general surgeon
with a specialist interest in vascular surgery since,
1987 and has an additional specialist vascular and
endovascular consultant surgeon since, 2001. This
appointment has led to a change in referral pattern.
Patients with CLI, who were traditionally referred to
specialized units outside our catchment area for
evaluation and treatment, are now being managed
within our institution.Data recovery
Data was retrieved from our hospital inpatient enquiry
(HIPE) department and VascuBase. Follow-up data
was obtained from medical records and a phone
survey of general practitioners.Inclusion criteria
Only patients with limb threatening ischaemia, who
had some form of intervention, were entered into the
study. All patients had rest pain, ulcers, or gangrene
caused by peripheral arterial occlusive disease
(Rutherford categories 4–6)2 with an ankle brachial
index (ABI) of less than 0.5 or a reduced toe pressure
(!30–50 mmHg).3Amputation
Major amputation was defined as any amputation
above the level of the ankle, i.e. below-knee amputa-
tion or above-knee amputation. Trans metatarsalEur J Vasc Endovasc Surg Vol 30, September 2005amputation is seen as a minor amputation and
known as leg-sparing surgery, which is now performed
in preference to repeated ray amputations. Primary
amputation was defined as amputation of the ischae-
mic limb without an antecedent attempt at revascular-
isation, and was considered in those cases in which the
arterial disease was not amenable to reconstruction
due to the progressive nature of the underlying
atherosclerotic occlusive disease. In patients with no
vessel run-off, combined with an ABI less than 0.2 with
no digital pressures, vascular reconstruction was
deemed impossible and these patients were con-
sidered best served by a primary amputation. Second-
ary amputation was a major amputation, performed
on a patient who had some prior attempt at revascu-
larisation, i.e. they were members of either the SIA or
bypass groups.Investigations
Historically, the need for amputation was determined
by clinical examination of the leg by the general
surgeon on call, occasionally assisted by angiography.
ABIs were crudely performed by the surgeon, using
hand held Doppler. If an amputation was deemed
necessary the most distal level of amputation that will
heal was clinically assessed immediately before
surgery.
In recent years, modern imaging modalities, such as
duplex ultrasound and occasionally MRA, have
helped us demonstrate the complete absence of distal
vessels by non-invasive means. In 2001 a fully
dedicated vascular laboratory was opened in our
institution. Since, the ready availability of duplex
ultrasound, all patients have received pre-operative
ABI measurement and duplex scan as triage for
endovascular management, bypass surgery or pri-
mary amputation. Patients with heavily calcified
crural vessels and patients with echolucent material
in their iliac arteries underwent magnetic resonance
angiography (MRA).Subintimal or bypass?
Since 2001, SIA is used as first-line treatment in all
suitable patients. The only indications for surgical
bypass were the presence of an echolucent shadow in
the femoral artery, as visualised on duplex scan, and
the absence of a ‘nipple’.8 Both findings render the
lesion unsuitable for subintimal angioplasty. An
echolucent shadow in the femoral artery indicates
the presence of thrombus and the associated danger of
distal embolisation or re-thrombosis.8 The absence of a
A 15 Year Experience 293nipple (indicating a flush occlusion) makes it difficult
to initiate the subintimal dissection plane.8
Lesions !5 cm (TASC A or B) are treated by
intraluminal angioplasty, as recommended by the
TASC working group and were not included in this
study.3 SIA was used for both femeropopliteal and iliac
occlusions based on a definition of SIA as endovas-
cular management of arterial occlusive lesionsO5 cm
in length (i.e. TASC C and D lesions).3 All lesions
treated post-SIA were either TASC C or D, as seen on
intra-operative angiogram.
All SIA procedures were performed in theatre using
the OEC mobile c-arm imaging system (GE, USA). All
patients were brought to the operating theatre on an
intention-to-treat basis. If more than one lesion was
treated, the patient was assigned to a group as per the
most proximal lesion treated.
Since 2001, 80% of the bypass procedures were
performed by the dedicated vascular and endovascu-
lar surgeon, while the other 20% were divided
between two general surgeons, one with vascular
interests, and the other who referred his patients to the
interventional radiology department for intervention.
All of these patients are excluded from the study.Pre-operative assessment
Since 2001, preoperative cardiorespiratory evaluation
is performed on all patients and includes a careful
clinical assessment, with all patients undergoing
preoperative echocardiography and pulmonary func-
tion testing. While general or spinal anesthesia is used
in bypass surgery, regional anesthesia with haemody-
namic monitoring is used for SIA.Adjuvant pharmacological treatment
All patients in the post-SIA group were treated with
aspirin, pravastatin and cardioselective beta-blocker
peri- and postoperatively. Post-operatively we add
clopidogrel for 1 year. This ‘magic bullet’ aims to
reduce cardiovascular morbidity and mortality, and
failures due to thrombosis, myo-intimal hyperplasia,
or further progression of atherosclerosis. We have
previously shown that this treatment statistically
improves the overall outcome of high-risk patients
with peripheral vascular disease.42Follow-up
Prior to 2001, patients were seen at 1 and 6 months
post-discharge for clinical assessment and ABImeasurement. However, this was not fixed and varied
per patient. A surveillance programme was initiated in
2001, and the post-SIA group were seen at 6-weeks, 3
months, 6 months, 9 months and yearly thereafter.
This programme allows for early detection and
management of restenosis and consequently high
assisted primary patency and secondary patency
rates. It consists of ABI measurement and duplex
scanning of the entire length of the graft, with
calculation of peak systolic velocities and the velocity
ratios across all identified lesions. A stenosis of
between 50 and 75% on duplex scan, together with a
drop in ABI ofO0.15, in the presence of deterioration
in clinical status, was taken as an indication for re-
intervention.3,8Treatment analysis
The patients were divided into two groups depending
on whether they were treated prior to or post the
availability of subintimal angioplasty (SIA) in 2001.
The two groups were compared with respect to age,
sex, ASA grade, Rutherford classification, level of
disease and the presence of diabetes mellitus. Out-
come was assessed by the limb salvage rate, 30-day
morbidity and mortality, and length of hospital stay.
As per HIPE records hospital stay included the total
time spent for each hospital stay. This included time
spent under other consultants during the same visit,
prior to referral to the vascular team; time spent on
pre-operative anaesthetic assessment and optimis-
ation; time spent managing co-morbid conditions;
and time spent awaiting placement in nursing homes
and respite facilities.Statistical analysis
Cumulative limb salvage rates were calculated separ-
ately for the pre- and post-SIA groups using actuarial
life table projections. Cumulative limb salvage rates
were calculated for the surgical bypass and SIA groups
using the same method. If a patient had undergone
more than one procedure, follow-up was started from
the first procedure. Also if the patient underwent more
than one major amputation, the first amputation was
counted as the event.
Demographic differences were assessed with Pear-
son’s chi-squared test for categorical variables and the
t-test for continuous variables. Multivariate analysis
was performed with a Cox proportional hazards
model to determine the effect of patient demographics
(i.e. age, sex, diabetes and other co-morbidities),
disease presentation and treatment modality onEur J Vasc Endovasc Surg Vol 30, September 2005
Table 1. Patient demographics
Pre-SIA Post-SIA
Number 938 330
M:F 64:26% 57:43%
Age 73 72
Diabetes mellitus 23% 21%
ASA grade III:IV 60:40% 58:42%
 
N. Hynes et al.294amputation-free survival rate. All p-values were
considered significant at 0.05. Statistical analyses
were performed with SPSS 12.0.1 for windows
software.Fig. 1.
Results
Over a 15 year, period from 1989 to 2004, 1268 patient
were treated for critical limb ischaemia. Eight hundred
twenty-nine patients (65%) underwent attempts at
revascularisation. Six hundred seventy-one patients
had peripheral bypass surgery and 158 had peripheral
endovascular procedures. In the same period 439
patients had primary amputations. Only 19% of
patients were lost to follow-up. Thirty-three percent
(221 patients) of those who had bypass surgery went
on to have a secondary amputation, while 5% (eight
patients) of those who had subintimal angioplasty
eventually lost their limb.
The patients were divided into two groups, depend-
ing on whether they presented prior to or since, the
availability of SIA (Table 1). There was no statistical
difference between the two groups with respect to age,
sex, ASA grade or the presence of diabetes. The
differences between the two groups in the presentation
(Rutherford classification) and level of the disease did
not reach statistical significance (Table 2).Limb salvage rates
The limb salvage rate was steady and averaged at 42%
prior to the introduction of SIA. The limb salvage rate
(70%) increased dramatically in 2001 with the intro-
duction of SIA (Fig. 1).Table 2. Disease presentation
Pre-SIA (%) Post-SIA (%)
Rutherford classification
6 36 31
5 17 16
4 47 53
Level of disease (principal lesion treated)
Aorto-iliac 28 27
Femero-popliteal 71 66
Infra-popliteal 1 7
Eur J Vasc Endovasc Surg Vol 30, September 2005Cumulative limb salvage rates
The 1 and 3 year cumulative limb salvage rates
following revascularisation are significantly higher in
the post-SIA group (85.6%, SE 2.24%; 85.6% SE, 2.30%)
when compared to the rates at the same time intervals
in the pre-SIA (71.9%, SE 1.95%; 68.1%, SE 2.09%) (Fig.
2).
The cumulative limb salvage rate following SIA
angioplasty is 97.8% (SE 1.10%) at 1 year and 97.2% (SE
1.26%) at 3 years. The corresponding rates, at 70.8%
(SE 1.86%) and 67.7% (SE 1.97%), respectively, are
substantially lower following bypass surgery (Figs. 3
and 4).Study endpoints (Table 8)
The limb salvage rate has increased significantly since,
the introduction of SIA (p!0.0001), but the level of
amputation has not changed. Thirty-day morbidity
and mortality were significantly lower in the post-SIAFig. 2.
Fig. 3. Limb salvage rates for total bypass and SIA
procedures.
Table 3. Patient demographics according to mode of treatment
Primary
amputation
Bypass SIA
Number 439 671 158
M:F 63:37% 67:33% 46:54%
Mean age 76 70 73
Octogenarians 41% 17% 35%
ASA grade
III:IV
37:63% 40:60% 25:75%
Diabetes mel-
litus
32% 18% 16%
A 15 Year Experience 295group (p!0.001, pZ0.005), as was the mean length of
stay (p!0.0001).Treatment analysis
The patients were also divided into groups depending
on mode of treatment (Table 3). While there were more
men in the primary amputation and bypass groups,
there were significantly more women in the subintimal
angioplasty group (p!0.01). The mean age of the
bypass group was significantly lower than either of the
other groups (p!0.01), and the proportion of octogen-
arians in the angioplasty group was significantly
higher than in the bypass group (p!0.01). The ASA
grade was similar among the groups (pZ0.17). The
clinical presentation of the disease was significantly
worse in the primary amputation group (p!0.001)
when compared to either of the other two groups and
significantly worse in the SIA group when compared
to the bypass group (pZ0.0012). There were a
significantly higher percentage of diabetics in the
primary amputation group (p!0.05).
The mean length of hospital stay needed for the
primary procedure was significantly lower in the SIA
group when compared to either the bypass or primaryFig. 4. Limb salvage rates for bypass and SIA procedures
done after 2001.amputation groups (p!0.01). This level of significance
remains even when the mean total number days spent
in hospital for all admissions is taken into account. The
mean number of admissions per patient was the same
for the SIA and bypass groups, but the average
number of procedures per patient was significantly
increased in the bypass group when compared to the
SIA group (p!0.0001) (Table 4).
Thirty-day morbidity and 30-day mortality were
significantly lower in the SIA group than in either of
the other two groups (p!0.001 for both) (Table 5).
A significantly higher proportion of patients in the
SIA group were fit to be discharged home than in
either of the other two groups (p!0.01). More patients
were discharged to a nursing home in the primary
amputation group than in the other groups (p!0.01),
while the number of patients who died before
discharge was significantly lower in the SIA group
than in either of the other two groups [p!0.05
(bypass); p!0.01 (primary amputation)] (Table 6).
Using multivariate analysis the factors that were
shown to increase the overall risk of amputation were
renal failure and diabetes (Table 9).Discussion
In view of the poor outcome associated with CLI, the
European consensus document recommends revascu-
larisation for the treatment of CLI if there is over 25%
chance of patient survival and limb salvage for 1 year.1Table 4. Comparison of length of stay between treatment
modalities
Primary amputation Bypass SIA
Mean length of stay
for primary pro-
cedure (days)
49 36 17
Mean length of stay
for all admissions
50 45 23
Mean no. of admis-
sions
1 1.3 1.3
Mean no. of pro-
cedures
1 1.6 1.3
Eur J Vasc Endovasc Surg Vol 30, September 2005
Table 5. 30-day morbidity and mortality
Primary
amputation
(%)
Bypass sur-
gery (%)
Subintimal
angioplasty
(%)
30-day mor-
tality
19 12 4
30-day mor-
bidity
49 32 19
N. Hynes et al.296However, it is impossible to accurately predict the
longevity of any individual patient, and to date, there
have been no prospective studies or clinical trials that
have confirmed criteria that allow us to differentiate
patients with CLI at high risk for early mortality, for
whom revascularisation may be irrelevant, from those
patients who are likely to survive a number of years
and in whom aggressive attempts at limb salvage
would be appropriate. On a population level, however,
the efficacy of vascular surgery has been previously
demonstrated9–12 and it has been shown that an
increase in vascular reconstructions correlates with
an increase in limb salvage rates.13–16 No study before
this has examined the specific role of subintimal
angioplasty on amputation trends in critical limb
ischaemia.
Studies that have examined the association between
revascularisation procedures and amputation rate, in
an attempt to identify the population-based thera-
peutic effectiveness of revascularisation to treat CLI17–22
have assumed that if revascularisation procedures
avert the need for amputation in some patients, then a
negative correlation should exist between rates of
amputation and revascularisation procedures.18 This
is not necessarily the case and while many population-
based studies have reported decreased rate of
amputation in association with increased use of
revascularisation procedures,17,23,24 other studies
showed no change in lower extremity amputation
rate.17,23–27 Al-Omran et al.18 found in a retrospective
population-based cohort study over an 8-year period,
that the revascularisation rate remained stable, with a
reduction in the use of bypass surgery and increased
use of angioplasty. This is in contrast to our study,
in which the number of attempted revascularisations
has effectively doubled since, the introduction ofTable 6. Discharge details
Primary
amputation
(%)
Bypass (%) SIA (%)
Home 57 79 86
Nursing home 19 5 4
Other hospital 5 4 5
RIP 18 10 3
Other 1 2 2
Eur J Vasc Endovasc Surg Vol 30, September 2005subintimal angioplasty from an average of 53 per
year (SEG2.27) to 96 per year (SEG13.69) (pZ0.0001).
This increase in the number of revascularisations has
not resulted in a parallel rise in the number of
secondary amputations. In fact the proportion of
revascularisations ending with secondary amputa-
tions has significantly reduced (p!0.01). In addition
the number of primary amputations has remained
steady since, 1989, averaging at 32 per year (SEG
2.172). The adoption of SIA, within a new, dedicated
specialized vascular unit, has resulted in an increase in
peripheral revascularisation, with an increased limb
salvage rate but no decline in the number of lower-
extremity amputations.
Although the number of patients presenting has
dramatically increased, no difference exists in the
grade of disease being treated since, 2001 (Table 2),
which is not surprising if one follows the strict criteria
for definition of CLI.3 The establishment of a special-
ized vascular unit, and the availability of new
specialized techniques has led to a sudden and
dramatic increase in the diagnosis of peripheral
vascular disease, and expanded indications for pro-
cedural interventions. So, although the incidence of
CLI within our catchment area has not suddenly and
dramatically changed, the number of patients being
referred to our service, who were traditionally referred
outside our catchment area for evaluation and treat-
ment, has substantially increased.
In general the ratio of below-knee (BK) to above-
knee (AK) is near 1 and has not changed over the
years, even with a rise in revascularisation rates.3 The
rationale for primary below-knee amputation assumes
that patients will ambulate successfully with prosthe-
sis. Studies on the rate of rehabilitation following
lower limb amputation have shown that, while most
above knee amputees are wheelchair bound or bed-
ridden, and in need of full-time care, up to 80% of
patients with below knee amputations can achieve full
ambulation with the aid of prosthesis.19 However,
with a population that is aging, increasingly obese,
and with extensive co-morbid conditions, ambulation
for all patients with BK amputations may be imprac-
tical.20 One review on the functional outcome in a
contemporary series of major lower extremity ampu-
tations found that, in a population that is clinically and
physiologically severely ill, a significant number of
amputees are unable to regain bipedal gait despite
aggressive rehabilitation.21 But despite a low rate of
postoperative ambulation, most patients remain living
in the community.
Previous studies by our group have shown that SIA
can achieve symptomatic patency rates of 95% and a
reduction in length of hospital stay by minimally
Table 8. Primary endpoints
Pre-SIA (%) Post-SIA (%)
Limb salvage rate 42 70
AKA:BKA 40:60 60:40
30-day morbidity 38 21
30-day mortality 16 7
Table 9. Cox proportional hazards model: risk factors for major
amputation
A 15 Year Experience 297invasive means.8 In this study, SIA was successfully
used in a group in which over one third were
octogenarians (Table 3). With a cumulative 1-year
limb salvage rate of 97% and a mean length of hospital
stay less than half that of other treatment modalities.
The mean number of admissions was the same as the
bypass group but the length of hospital stay for total
admissions was significantly lower in the SIA group,
as was the average number of procedures per patient
and the 30-day mortality rate (Tables 7 and 8). Any of
these alone or in combination add to an overall
reduction in the cost per patient. One British study
estimated the median costs of treating critical ischae-
mia to be 6611 pounds for angioplasty, 6766 pounds for
bypass, and 10,162 pounds for primary amputation.28
The authors concluded that, with the median cost of
managing a patient following amputation almost
twice that of successful limb salvage, an aggressive
revascularisation policy was justified, and this con-
clusion has been echoed by our group and others
(Table 4).8,29,30
The incidence of diabetes, especially type 2, in our
population is increasing as our population ages.31,32
Diabetes is known to be associated with increased
calcification, multi-level disease and infrapopliteal
lesions, as well as a mortality rate up to ten times
higher than in non-diabetics.28 However, it has been
shown that diabetics can benefit from a bypass
operation to the same degree as non-diabetics in
terms of patency and limb salvage.33 Although
subintimal angioplasty has been shown to successfully
achieve recanalization of long occluded arterial seg-
ments,8,34,35 its specific role in diabetic patients has not
been widely studied. We found that diabetics were
more likely to have an amputation than non-diabetics
(pZ0.029), a finding reflected in previous studies.36
However, in those patients deemed suitable for
revascularisation, there was no statistical significant
difference in the limb salvage rate between diabetic
and non-diabetic patients. This is again in accordance
with other studies.34 However, diabetics were more
likely to have an amputation after bypass surgery than
after SIA (p!0.05). Our high limb salvage rate in
diabetics following SIA is helped by a number of
factors, including a strict protocol in diabetic patientsTable 7. Comparison of length of stay pre- and post SIA
Pre-SIA Post-SIA
Mean length of stay for primary
procedure (days)
43 22
Mean length of stay for all admis-
sions (days)
49 27
Mean no. of admissions 1.2 1.2
Mean no. of procedures 1.8 2of primary transmetatarsal amputation rather than
repeated digital amputations. This is based on clinical
experience and recognition of the biomechanical
factors that are specific to diabetics,37 such as plantar
fascia abnormalities and increased vertical plantar
pressures under the metatarsal heads of the forefoot,
which lead to a more rigid foot.
Our data showed an unequivocal shift in patients to
our practice with CLI, characterized by increasing age,
an increased proportion of women, and a higher
prevalence of diabetes mellitus and renal disease.
Using multivariate analysis, the co-morbid factors that
had negative impact on limb salvage were diabetes (p
K0.029) and renal insufficiency (pZ0.006), factors well
recognized by other authors.33
Although the literature is consistent regarding a
lack of significant effect of diabetes and advanced age
on revascularisation results, the question of gender-
based differences in outcome remains controversial.38,39
We found no significant association between gender,
major adverse events or risk of amputation.40 Women
were on average older than their male counterparts (75
vs. 71 years, p!0.0001), but unlike previous studies
there was no corresponding disimprovement in dis-
ease pattern.41
CLI has major implications for health costs and
most vascular units workload, but our results show
that despite a changing patient population with
increased co-morbidity, more advanced ischemia,
and a need for greater technical complexity, technical
advances have resulted in a steadying of amputation
numbers. SIA has broadened our indications for
intervention but yet the need for primary amputation
still exists, suggesting that patients undergoing vas-
cular reconstruction and those undergoing primaryRisk factor Risk ratio 95% confi-
dence interval
p
AgeO80 years 1.294 0.921–1.820 0.138
Male gender 1.103 0.783–1.554 0.575
Heart disease 0.925 0.535–1.595 0.778
Diabetes mel-
litus
1.610 1.395–1.941 0.029*
Renal failure 2.253 1.257–4.039 0.006*
SIA 0.774 0.582–1.028 0.077
* Significant at p!0.05 level.
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N. Hynes et al.298amputation may represent different population cat-
egories. The later category mostly consists of patients
presenting too late, with tissue loss too extensive to
enable limb salvage. Risk of amputation following
revascularisation procedures is positively associated
with type of procedure, and diabetic and renal status.
SIA plays a major role in the initial management of
CLI, because it is cost effective, minimally invasive,
associated with a high limb salvage rate, and is
preferred by patients.References
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